CTRI/2023/05/053235进行中（未招募）Unknown
A single-arm, multicentre, Post-marketing observational follow up on patients who have been given Gadolinium for clinical scans to detect all prospective adverse events immediately post dose and 6 (±2) weeks after administration of Omniscan
GE HealthCare Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.GBCA-naïve male/female patients of at least 18 years of age.
- •2.Patients willing to participate in the active surveillance and agree to be contacted by phone after 6 (±2) weeks after the MR scan for brief interviews.
排除标准
- •1.Patients known to have hypersensitivity to Omniscan or its constituents.
- •2.Patients with chronic, severe kidney disease (GFR <30ml/min/1.73m2), or acute kidney injury.
研究者
相似试验
招募中
4 期
A Study to assess the safety and efficacy of FDC of Propranolol Hydrochloride IP Plus Clonazepam IP Tablets in patients with anxiety disorders.CTRI/2020/07/026634Akums Drugs Pharmaceuticals Limited
尚未招募
不适用
A multicentre, post-marketing, prospective, observational study to evaluate the safety and performance of the Apex Total Knee Replacement system.OsteoarthritisACTRN12618000441213Global Orthopaedic Technology1,000
招募中
4 期
Evaluation of Effectiveness And Safety Of Clarithromycin In Upper Respiratory Tract InfectioCTRI/2024/06/069427Abbott Healthcare Private Limited
进行中（未招募）
1 期
Post marketing surveillance to collect safety information after vaccination with Bexsero administered in routine care and according to prescribing information in Korea.The study will collect real-world post-vaccination adverse events.EUCTR2023-000765-14-Outside-EU/EEAGlaxoSmithKline Biologicals SA
已完成
4 期
Superia: Sirolimus Eluting Coronary Stent System (SSECSS) India Post Marketing RegistryCTRI/2012/01/002393Innvolution Med System200